000 01303 a2200325 4500
005 20250514062218.0
264 0 _c20030724
008 200307s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/s00228-002-0556-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaufs, Ulrich
245 0 0 _aBeyond lipid-lowering: effects of statins on endothelial nitric oxide.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_cMar 2003
300 _a719-31 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aArteriosclerosis
_xdrug therapy
650 0 4 _aCholesterol
_xbiosynthesis
650 0 4 _aClinical Trials as Topic
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xpharmacology
650 0 4 _aHypercholesterolemia
_xdrug therapy
650 0 4 _aHypolipidemic Agents
_xpharmacology
650 0 4 _aMevalonic Acid
_xmetabolism
650 0 4 _aNitric Oxide
_xbiosynthesis
650 0 4 _aOxidative Stress
_xdrug effects
773 0 _tEuropean journal of clinical pharmacology
_gvol. 58
_gno. 11
_gp. 719-31
856 4 0 _uhttps://doi.org/10.1007/s00228-002-0556-0
_zAvailable from publisher's website
999 _c12429592
_d12429592